Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Aug;118(2):369-381.
doi: 10.1016/j.ajcnut.2023.06.008. Epub 2023 Jun 12.

A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study

Affiliations
Randomized Controlled Trial

A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study

David Vauzour et al. Am J Clin Nutr. 2023 Aug.

Abstract

Background: There is evidence that both omega-3 long-chain polyunsaturated fatty acids (PUFAs) (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and cocoa flavanols can improve cognitive performance in both healthy individuals and in those with memory complaints. However, their combined effect is unknown.

Objectives: To investigate the combined effect of EPA/DHA and cocoa flavanols (OM3FLAV) on cognitive performance and brain structures in older adults with memory complaints.

Methods: A randomized placebo-controlled trial of DHA-rich fish oil (providing 1.1 g/d DHA and 0.4 g/d EPA) and a flavanol-rich dark chocolate (providing 500 mg/d flavan-3-ols) was conducted in 259 older adults with either subjective cognitive impairment or mild cognitive impairment. Participants underwent assessment at baseline, 3 mo, and 12 mo. The primary outcome was the number of false-positives on a picture recognition task from the Cognitive Drug Research computerized assessment battery. Secondary outcomes included other cognition and mood outcomes, plasma lipids, brain-derived neurotrophic factor (BDNF), and glucose levels. A subset of 110 participants underwent structural neuroimaging at baseline and at 12 mo.

Results: 197 participants completed the study. The combined intervention had no significant effect on any cognitive outcomes, with the exception of reaction time variability (P = 0.007), alertness (P < 0.001), and executive function (P < 0.001), with a decline in function observed in the OM3FLAV group (118.6 [SD 25.3] at baseline versus 113.3 [SD 25.4] at 12 mo for executive function) relative to the control, and an associated decrease in cortical volume (P = 0.039). Compared with the control group, OM3FLAV increased plasma HDL, total cholesterol ratio (P < 0.001), and glucose (P = 0.008) and reduced TG concentrations (P < 0.001) by 3 mo, which were sustained to 12 mo, with no effect on BDNF. Changes in plasma EPA and DHA and urinary flavonoid metabolite concentrations confirmed compliance to the intervention.

Conclusions: These results suggest that cosupplementation with ω-3 PUFAs and cocoa flavanols for 12 mo does not improve cognitive outcomes in those with cognitive impairment. This trial was registered at clinicaltrials.gov as NCT02525198.

Keywords: aging; cognition; flavonoids; mild cognitive impairment; omega-3; polyphenols; subjective cognitive impairment.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
CONSORT flowchart diagram. A total of N = 258 participants were randomly assigned to either a DHA-rich fish oil and cocoa flavanol mixture (OM3FLAV; n = 129) or a control product (n = 129).
FIGURE 2
FIGURE 2
Impact of 3-mo and 12-mo consumption of a DHA-rich fish oil and cocoa flavanol mixture (OM3FLAV; n = 104 at 3 mo and n = 95 at 12 mo) or a control product (n = 108 at 3 mo and n = 102 at 12 mo) on plasma fatty acid profiles and urinary excretion of a flavanol metabolite. (A) Non-esterified AA (NEFA AA); (B) Non-esterified eicosapentaenoic acid (NEFA EPA); (C) Non-esterified docosahexaenoic acid (NEFA DHA); (D) Hydroxyphenyl-γ-valearolactone sulfate. Data are presented as floating bars (min-max) with the horizontal line indicating the mean. Bar colors are as follows: blue (baseline), green (3 mo), and red (12 mo).
FIGURE 3
FIGURE 3
Picture recognition new stimuli accuracy (%) at baseline and following 3 mo or 12 mo of a DHA-rich fish oil and cocoa flavanol mixture (OM3FLAV; n = 104 at 3 mo and n = 95 at 12 mo) or a control product (n = 108 at 3 mo and n = 102 at 12 mo). Data are presented as floating bars (min-max) with the horizontal line indicating the mean. Bar colors are as follows: blue (baseline), green (3 mo), and red (12 mo).
FIGURE 4
FIGURE 4
Structural MRI assessment of (A) hippocampal volume; (B) cortical volume; (C) cortical white matter volume; and (D) ventricular volume following 12-mo consumption of a DHA-rich fish oil and cocoa flavanol mixture (OM3FLAV; n = 48) or a control product (n = 62). Data are presented as floating bars (min-max) with the horizontal line indicating the mean. Bar colors are as follows: blue (baseline) and red (12 mo).

Comment in

References

    1. Colantuoni E., Surplus G., Hackman A., Arrighi H.M., Brookmeyer R. Web-based application to project the burden of Alzheimer’s disease. Alzheimers Dement. 2010;6(5):425–428. doi: 10.1016/j.jalz.2010.01.014. - DOI - PubMed
    1. Lewis F., Schaffer S.K., Sussex J., O’Neill P., Cockcroft L. Office of Health Economics (OHE) Contract Research; 2014. The Trajectory of Dementia in the UK – Making a Difference.https://www.ohe.org/publications/trajectory-dementia-uk-making-difference/ [Internet] Available from:
    1. Pottala J.V., Yaffe K., Robinson J.G., Espeland M.A., Wallace R., Harris W.S. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology. 2014;82(5):435–442. doi: 10.1212/wnl.0000000000000080. - DOI - PMC - PubMed
    1. Zhang Y., Chen J., Qiu J., Li Y., Wang J., Jiao J. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr. 2016;103(2):330–340. doi: 10.3945/ajcn.115.124081. - DOI - PubMed
    1. Zhang Y., Zhuang P., He W., Chen J.N., Wang W.Q., Freedman N.D., et al. Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. J. Intern. Med. 2018;284(4):399–417. doi: 10.1111/joim.12786. - DOI - PubMed

Publication types

Associated data